DE2136624A1 - N (6)-substituierte adenosin-derivate und verfahren zur herstellung derselben - Google Patents

N (6)-substituierte adenosin-derivate und verfahren zur herstellung derselben

Info

Publication number
DE2136624A1
DE2136624A1 DE2136624A DE2136624A DE2136624A1 DE 2136624 A1 DE2136624 A1 DE 2136624A1 DE 2136624 A DE2136624 A DE 2136624A DE 2136624 A DE2136624 A DE 2136624A DE 2136624 A1 DE2136624 A1 DE 2136624A1
Authority
DE
Germany
Prior art keywords
general formula
adenosine
chloro
hydrogen
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2136624A
Other languages
German (de)
English (en)
Inventor
Erich Dr Fauland
Wolfgang Dr Med Juhran
Wolfgang Dr Rer Nat Kampe
Harald Dr Med Stork
Max Dr Rer Nat Thiel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE2136624A priority Critical patent/DE2136624A1/de
Priority to GB3353772A priority patent/GB1340643A/en
Priority to US00271098A priority patent/US3845035A/en
Priority to ZA724891A priority patent/ZA724891B/xx
Priority to AR243105A priority patent/AR192658A1/es
Priority to CH1079572A priority patent/CH570420A5/xx
Priority to CH1061775A priority patent/CH569035A5/xx
Priority to ES405022A priority patent/ES405022A1/es
Priority to SU1812966A priority patent/SU539532A3/ru
Priority to CA147,625A priority patent/CA979891A/en
Priority to NL7210023A priority patent/NL7210023A/xx
Priority to HU72BO00001387A priority patent/HU171081B/hu
Priority to FR7226450A priority patent/FR2146493B1/fr
Priority to AT628872A priority patent/AT317446B/de
Priority to AT790673*7A priority patent/AT327405B/de
Priority to AR245831A priority patent/AR193000A1/es
Publication of DE2136624A1 publication Critical patent/DE2136624A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2136624A 1971-07-22 1971-07-22 N (6)-substituierte adenosin-derivate und verfahren zur herstellung derselben Pending DE2136624A1 (de)

Priority Applications (16)

Application Number Priority Date Filing Date Title
DE2136624A DE2136624A1 (de) 1971-07-22 1971-07-22 N (6)-substituierte adenosin-derivate und verfahren zur herstellung derselben
GB3353772A GB1340643A (en) 1971-07-22 1972-06-18 N-6- substituted adenosine derivatives
US00271098A US3845035A (en) 1971-07-22 1972-07-12 Novel n(6)-substituted adenosine compounds and therapeutic compositions
ZA724891A ZA724891B (en) 1971-07-22 1972-07-17 New n(6)-substituted adenosine derivatives and the preparation thereof
AR243105A AR192658A1 (es) 1971-07-22 1972-07-17 Un procedimiento para la preparacion de derivados de la adenosina
CH1079572A CH570420A5 (enExample) 1971-07-22 1972-07-19
CH1061775A CH569035A5 (enExample) 1971-07-22 1972-07-19
ES405022A ES405022A1 (es) 1971-07-22 1972-07-20 Procedimiento para la preparacion de derivados de adenosi- na.
SU1812966A SU539532A3 (ru) 1971-07-22 1972-07-20 Способ получени (6)замещенных производных аденозина
CA147,625A CA979891A (en) 1971-07-22 1972-07-20 N(6)-aralkyl-adenosine derivatives and process for the preparation thereof
NL7210023A NL7210023A (enExample) 1971-07-22 1972-07-20
HU72BO00001387A HU171081B (hu) 1971-07-22 1972-07-21 Sposob poluchenija zamehhennykh proizvodnykh n-skobka-6-skobka zakryta-benzil-adenozina
FR7226450A FR2146493B1 (enExample) 1971-07-22 1972-07-21
AT628872A AT317446B (de) 1971-07-22 1972-07-21 Verfahren zur Herstellung von neuen N(6)-substituierten Adenosin-Derivaten
AT790673*7A AT327405B (de) 1971-07-22 1972-07-21 Verfahren zur herstellung von neuen n(6)-substituierten adenosin-derivaten
AR245831A AR193000A1 (es) 1971-07-22 1972-12-26 Un procedimiento para la preparacion de derivados de la adenosina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2136624A DE2136624A1 (de) 1971-07-22 1971-07-22 N (6)-substituierte adenosin-derivate und verfahren zur herstellung derselben

Publications (1)

Publication Number Publication Date
DE2136624A1 true DE2136624A1 (de) 1973-02-08

Family

ID=5814433

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2136624A Pending DE2136624A1 (de) 1971-07-22 1971-07-22 N (6)-substituierte adenosin-derivate und verfahren zur herstellung derselben

Country Status (13)

Country Link
US (1) US3845035A (enExample)
AR (2) AR192658A1 (enExample)
AT (2) AT317446B (enExample)
CA (1) CA979891A (enExample)
CH (2) CH570420A5 (enExample)
DE (1) DE2136624A1 (enExample)
ES (1) ES405022A1 (enExample)
FR (1) FR2146493B1 (enExample)
GB (1) GB1340643A (enExample)
HU (1) HU171081B (enExample)
NL (1) NL7210023A (enExample)
SU (1) SU539532A3 (enExample)
ZA (1) ZA724891B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364862A (en) * 1990-09-25 1994-11-15 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive and anti-ischemic properties
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501735A (en) * 1983-12-05 1985-02-26 Warner-Lambert Company N6-(1- and 2-benzocycloalkyl) adenosines
US4657898A (en) * 1984-06-22 1987-04-14 Warner-Lambert Company N6 -substituted adenosines and method of use
FR2575751B1 (fr) * 1985-01-08 1987-04-03 Pasteur Institut Nouveaux nucleosides de derives de l'adenosine, leur preparation et leurs applications biologiques
US5284834A (en) * 1985-03-29 1994-02-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Adenosine functionalized congeners as cardiovascular treating agents for animals and methods for using same
US4974683A (en) 1987-12-31 1990-12-04 Sukup Manufacturing Company Ridge tillage attachment for planters
JPH0725785B2 (ja) * 1989-01-11 1995-03-22 日本臓器製薬株式会社 アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物
WO1994002497A1 (en) * 1992-07-15 1994-02-03 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Sulfo-derivatives of adenosine
CZ294538B6 (cs) * 2002-12-30 2005-01-12 Ústav Experimentální Botaniky Akademie Vědčeské Re Substituční deriváty N6-benzyladenosinu, způsob jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
US7897737B2 (en) 2006-12-05 2011-03-01 Lasergen, Inc. 3′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing
RU2324698C1 (ru) * 2007-02-05 2008-05-20 Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук Способ получения 2-хлораденозина
BRPI0915173B8 (pt) 2008-06-11 2021-05-25 Agilent Technologies Inc compostos de nucleotídeos e nucleosídeos e método de sequenciamento de um ácido nucleico-alvo
JP6196972B2 (ja) 2011-09-13 2017-09-13 レーザーゲン インコーポレイテッド ５−メトキシ３’−ｏｈ非遮断高速光開裂性末端ヌクレオチドおよび核酸配列決定のための方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364862A (en) * 1990-09-25 1994-11-15 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive and anti-ischemic properties
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties

Also Published As

Publication number Publication date
FR2146493A1 (enExample) 1973-03-02
CH570420A5 (enExample) 1975-12-15
CH569035A5 (enExample) 1975-11-14
AT327405B (de) 1976-01-26
NL7210023A (enExample) 1973-01-24
ES405022A1 (es) 1975-07-16
AR192658A1 (es) 1973-02-28
AT317446B (de) 1974-08-26
SU539532A3 (ru) 1976-12-15
ZA724891B (en) 1973-05-30
FR2146493B1 (enExample) 1976-04-16
ATA790673A (de) 1975-04-15
AR193000A1 (es) 1973-03-21
HU171081B (hu) 1977-11-28
GB1340643A (en) 1973-12-12
US3845035A (en) 1974-10-29
CA979891A (en) 1975-12-16

Similar Documents

Publication Publication Date Title
DE69834430T2 (de) Purin-Derivate zur Behandlung allergischer Erkrankungen und systemischem Lupus erythematodes
DE2136624A1 (de) N (6)-substituierte adenosin-derivate und verfahren zur herstellung derselben
DE69304883T2 (de) Xanthin Derivate
DE2628045A1 (de) Thieno(2,3-c)pyridinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DD216934A5 (de) Verfahren zur herstellung neuer derivate von xanthinen
DE69216221T2 (de) Verbindungen mit guanidin-struktur und diese enthaltende pharmazeutische zusammensetzungen
DE2056327A1 (de) Aminopunn Derivate
DE2918261C2 (enExample)
DE19602964A1 (de) Neue Morphinderivate, Verfahren zu deren Herstellung und deren Verwendung
DE2942365A1 (de) 2-hydroxyalkyl-3,4,5-trihydroxy-(pi)-peridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DD142048A5 (de) Verfahren zur herstellung von substituierten 2-phenylimino-imidazolidinen
DE2007273A1 (de) N(6) Aralkyl adenosin Derivate und Verfahren zur Herstellung derselben
DE1620567A1 (de) Tetrahydroisochinolin-Derivate und Verfahren zu ihrer Herstellung
DE2157036A1 (de) Neue heterocyclisch substituierte nebularin-derivate und verfahren zu deren herstellung
DE2059922A1 (de) Neue N(6)-Aralkyl-adenosin-Derivate und Verfahren zur Herstellung derselben
DE2804416A1 (de) Neue purin-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE2530515C2 (de) 4- bzw. 7-Hydroxy-4,5,6,7-tetrahydrothieno-[3,2-c] bzw.[2,3-c] pyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittelzubereitungen
DE2244328A1 (de) Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
CH629806A5 (en) Process for the preparation of substituted purines
DE1912848A1 (de) Verfahren zur Herstellung von neuen Derivaten des Sulfanilamids
DE1165032B (de) Verfahren zur Herstellung von Thioxanthenderivaten und deren Salzen
EP2159226B1 (de) Antihistamin- und antiallergienmittel sowie verfahren zu seiner herstellung
AT299202B (de) Verfahren zur Herstellung von neuen substituierten Isochinolinen und von deren Säureadditionssalzen
DE2633890A1 (de) Neue 7-amino-6,7-dihydro- eckige klammer auf 5h eckige klammer zu -benzocyclohepten-derivate und deren salze, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
DE2148838A1 (de) Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben

Legal Events

Date Code Title Description
OHA Expiration of time for request for examination